Literature DB >> 16996032

Hepatocyte-derived fibrinogen-related protein-1 is associated with the fibrin matrix of a plasma clot.

D C Rijken1, S P G Dirkx, T M Luider, F W G Leebeek.   

Abstract

In order to study the multiple functions of fibrinogen and fibrin, we are investigating which proteins bind to the fibrin matrix of a plasma clot by using a proteomic approach. Extracts from washed plasma clots were analysed by 2-D gel electrophoresis. A relatively abundant spot was identified as hepatocyte-derived fibrinogen-related protein-1 (HFREP-1) by MALDI-TOF analysis, molecular mass (34 kDa), iso-electric point (pI 5.5) as well as by Western blot analysis. HFREP-1 in plasma almost completely bound to the fibrin matrix during clot formation. Several purified fibrinogen preparations proved to be contaminated with HFREP-1. It is concluded that HFREP-1 (also named hepassocin), a protein with liver cell growth regulatory properties, occurs in plasma and strongly associates with fibrin and possibly fibrinogen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996032     DOI: 10.1016/j.bbrc.2006.09.018

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Cloning and expression analysis of the gene encoding fibrinogen-like protein A, a novel regeneration-related protein from Apostichopus japonicus.

Authors:  Yang Wu; Feng Yao; Yanli Mei; Bing Chu; Cheng Cheng; Yan Liu; Xuejie Li; Xiangyang Zou; Lin Hou
Journal:  Mol Biol Rep       Date:  2014-01-25       Impact factor: 2.316

2.  Fibrinogen-like protein 1, a hepatocyte derived protein is an acute phase reactant.

Authors:  Zhilin Liu; Chinweike Ukomadu
Journal:  Biochem Biophys Res Commun       Date:  2007-11-26       Impact factor: 3.575

3.  Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease.

Authors:  Peng Qu; Jennifer Roberts; Yuan Li; Marjorie Albrecht; Oscar W Cummings; John N Eble; Hong Du; Cong Yan
Journal:  Lung Cancer       Date:  2008-07-09       Impact factor: 5.705

4.  Identification of quantitative trait loci for fibrin clot phenotypes: the EuroCLOT study.

Authors:  Frances M K Williams; Angela M Carter; Bernet Kato; Mario Falchi; Lise Bathum; Gabriela Surdulescu; Kirsten Ohm Kyvik; Aarno Palotie; Tim D Spector; Peter J Grant
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-01-15       Impact factor: 8.311

5.  Specific expression and regulation of hepassocin in the liver and down-regulation of the correlation of HNF1alpha with decreased levels of hepassocin in human hepatocellular carcinoma.

Authors:  Hai-Tao Yu; Miao Yu; Chang-Yan Li; Yi-Qun Zhan; Wang-Xiang Xu; Yong-Hui Li; Wei Li; Zhi-Dong Wang; Chang-Hui Ge; Xiao-Ming Yang
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

6.  A Double-Antibody Sandwich ELISA for Sensitive and Specific Detection of Swine Fibrinogen-Like Protein 1.

Authors:  Xin Zhang; Haipeng Zhu; Xu Zheng; Yunjie Jiao; Lulu Ning; En-Min Zhou; Yang Mu
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

7.  Identification of fibrin clot-bound plasma proteins.

Authors:  Simone Talens; Frank W G Leebeek; Jeroen A A Demmers; Dingeman C Rijken
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

8.  Quantitative determination of fibrinogen of patients with coronary heart diseases through piezoelectric agglutination sensor.

Authors:  Qinghai Chen; Xing Hua; Weiling Fu; Dongbo Liu; Ming Chen; Guoru Cai
Journal:  Sensors (Basel)       Date:  2010-03-16       Impact factor: 3.576

9.  Targeted deletion of fibrinogen like protein 1 reveals a novel role in energy substrate utilization.

Authors:  Valeriy Demchev; Geraldine Malana; Divya Vangala; Janis Stoll; Anal Desai; Hye Won Kang; Yingxia Li; Hamed Nayeb-Hashemi; Michele Niepel; David E Cohen; Chinweike Ukomadu
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

10.  Distribution and medical impact of loss-of-function variants in the Finnish founder population.

Authors:  Elaine T Lim; Peter Würtz; Aki S Havulinna; Priit Palta; Taru Tukiainen; Karola Rehnström; Tõnu Esko; Reedik Mägi; Michael Inouye; Tuuli Lappalainen; Yingleong Chan; Rany M Salem; Monkol Lek; Jason Flannick; Xueling Sim; Alisa Manning; Claes Ladenvall; Suzannah Bumpstead; Eija Hämäläinen; Kristiina Aalto; Mikael Maksimow; Marko Salmi; Stefan Blankenberg; Diego Ardissino; Svati Shah; Benjamin Horne; Ruth McPherson; Gerald K Hovingh; Muredach P Reilly; Hugh Watkins; Anuj Goel; Martin Farrall; Domenico Girelli; Alex P Reiner; Nathan O Stitziel; Sekar Kathiresan; Stacey Gabriel; Jeffrey C Barrett; Terho Lehtimäki; Markku Laakso; Leif Groop; Jaakko Kaprio; Markus Perola; Mark I McCarthy; Michael Boehnke; David M Altshuler; Cecilia M Lindgren; Joel N Hirschhorn; Andres Metspalu; Nelson B Freimer; Tanja Zeller; Sirpa Jalkanen; Seppo Koskinen; Olli Raitakari; Richard Durbin; Daniel G MacArthur; Veikko Salomaa; Samuli Ripatti; Mark J Daly; Aarno Palotie
Journal:  PLoS Genet       Date:  2014-07-31       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.